Current Report Filing (8-k)
April 06 2021 - 04:43PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 6, 2021
Outset Medical, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-39513
|
|
20-0514392
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
file number)
|
|
(I.R.S. Employer
Identification Number)
|
3052 Orchard Dr.
San Jose, California 95134
(669) 231-8200
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock, par value $0.001 per share
|
|
OM
|
|
The Nasdaq Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
On April 6, 2021, Outset Medical, Inc. (the Company), issued a press release announcing that it has launched a public offering of 5,000,000
shares of the Companys common stock, par value $0.001 per share (the Common Stock), including shares to be issued by the Company and shares held by certain selling stockholders of the Company (the Offering). In
addition, the Company and such selling stockholders are expected to grant the underwriters a 30-day option to purchase up to an additional 750,000 shares of Common Stock. A copy of the press release is
attached hereto as Exhibit 99.1.
Item 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
Outset Medical, Inc.
|
Dated: April 6, 2021
|
|
|
|
By:
|
|
/s/ Rebecca Chambers
|
|
|
|
|
Name:
|
|
Rebecca Chambers
|
|
|
|
|
Title:
|
|
Chief Financial Officer
|
Outset Medical (NASDAQ:OM)
Historical Stock Chart
From Feb 2024 to Mar 2024
Outset Medical (NASDAQ:OM)
Historical Stock Chart
From Mar 2023 to Mar 2024